Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Felodipine ER vs Plendil in Healthy Males
NCT02327247Phase 1Completed
- Sponsor
- Ranbaxy Laboratories
- Start
- Sep 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of felodipine in hypertension (HTN) (2 arms), sponsored by Ranbaxy Laboratories. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started Sep 2008; status: completed.
02
Drugs
felodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02327247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327247.